Targeting altered Nme heterooligomerization in disease?

Oncotarget. 2017 Nov 27;9(2):1492-1493. doi: 10.18632/oncotarget.22716. eCollection 2018 Jan 5.

Authors

Issam H Abu-Taha¹, Christiane Vettel¹, Thomas Wieland¹

Affiliation

¹ Institute of Experimental and Clinical Pharmacology and Toxicology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; DZHK (German Center for Cardiovascular Research), Partner Site, Heidelberg-Mannheim, Germany.

No abstract available

Keywords: Nm23; Nme; cancer metastasis; heart failure; myocardial contraction.

Publication types

Editorial